These data clearly show that RANKL-treatment was unable to restore prion accumulation in the Peyer’s patches and MLN of RANKΔIEC mice, indicating that the major effects of RANKL-treatment on oral prion disease pathogenesis were due to effects on M cell-deficiency in the intestinal epithelium. This evidence concerns the gene TNFSF11 and prion disease.